ASX:ACW

Email Alerts for:
ASX:ACW

Stocks of the Hour: Lake Resources, Talon Energy, Actinogen Medical

26 Sep 2023 - A snapshot of the stocks on the move, featuring Lake Resources (ASX:LKE), Talon Energy (ASX:TPD) and Actinogen Medical (ASX:ACW).

Aus shares lower despite a spike in US markets: ASX down 0.15% at noon

30 Jan 2023 - The global race for lithium, a commodity crucial for the electric vehicle (EV) industry, has intensified as German Chancellor Olaf Scholz signed an agreement with Arg…

Actinogen Medical (ASX:ACW) - Webinar Presentation

24 Oct 2022 - Dr. Steven Gourlay - Managing Director & CEO - Actinogen Medical is a biotechnology company developing an innovative treatment for cognitive impairment associated wit…

A bad ending to last week leads to a poor start this week: ASX down 1.4%

10 Oct 2022 - It was a poor start to the week, as all sectors finished in the red, falling by 1.4 per cent or 95 basis points to 6667.80.

Stocks of the Hour: Helix Resources, Actinogen Medical, Galileo Mining

10 Oct 2022 - A snapshot of the stocks on the move featuring Helix Resources (ASX:HLX), Actinogen Medical (ASX:ACW) and Galileo Mining (ASX:GAL).

Rough start to the week, all sectors in the red: ASX down 1.4 per cent at noon

10 Oct 2022 - It was always going to be a dismal start to the trading week following Wall Street tumbling on Friday, after a stronger-than-expected jobs report raised the likelihoo…

Actinogen Medical (ASX:ACW) tackling Alzheimer's by inhibiting excess cortisol production in the brain

11 Nov 2020 - Actinogen Medical Limited (ASX:ACW) Managing Director and CEO Dr Bill Ketelbey provides an update on the company, discussing its lead drug candidate Xanamem, clinical…

Actinogen Medical (ASX:ACW) Presentation, FNN Online Investor Event, July 2020

31 Jul 2020 - Actinogen Medical Limited (ASX:ACW) CEO and Managing Director, Dr Bill Ketelbey talks about Xanamem, XanaHES trial and potential partnerships.

Actinogen Medical (ASX:ACW) Phase II Alzheimer’s trials

25 Sep 2018 - Actinogen Medical Limited (ASX:ACW) Managing Director and CEO, Dr Bill Ketelbey provides an update on the company's lead Alzheimer Phase II drug candidate XanADu and …

Actinogen Medical (ASX:ACW) Presentation, FNN Investor Event, September 2018, Sydney

24 Sep 2018 - Actinogen Medical Limited (ASX:ACW) Managing Director and CEO, Dr Bill Ketelbey presents an update on the company's lead Alzheimer Phase II drug candidate XanADu and …

Strong finish: ASX up 1.19% on first trading day

03 Jan 2017 - Strong finish: ASX up 1.19% on first trading day. Hills Ltd (ASX:HIL) enters contract with AMES Australasia, who will now manufacture and sell the Hills Home Living p…

Actinogen Medical gains FDA approval to start Alzheimer’s trial

03 Jan 2017 - US Food and Drug Administration (FDA) approves Actinogen Medical’s (ASX:ACW) application to start a Phase II clinical trial of its Alzheimer's drug, Xanamem.

Gold miners rally: ASX is 0.35% lower before noon

30 Dec 2016 - Gold miners rally: ASX is 0.35% lower before noon. Shine Corporate Ltd (ASX:SHJ) announces its founders will return to key roles after the resignation of Managing Dir…

Actinogen receives extension of patent in US

20 Jul 2016 - Actinogen Medical Ltd's (ASX:ACW) patent for Alzhemiers' drug extended in the US.

Actinogen: Presentation, CEO Sessions Brisbane

18 Nov 2015 - Actinogen Limited (ASX:ACW) CEO Dr Bill Ketelbey presents at the CEO Sessions in Brisbane

Actinogen discusses Xanamem Phase 1 results

18 Nov 2015 - Actinogen (ASX:ACW) Managing Director and CEO Dr Bill Ketelbey discusses the company’s latest trial results.

Actinogen: ASX Investor Series Perth

23 Jun 2015 - Actinogen Limited (ASX:ACW) CEO Dr Bill Ketelbey presents at the ASX Investor Series in Perth.

Actinogen's new approach to treating Alzheimer's

23 Jun 2015 - Actinogen Limited (ASX:ACW) CEO Dr Bill Ketelbey provides an update on the company’s development of treatment for Alzheimer’s disease.

Actinogen pursuing treatment of Alzheimer’s

27 April 2015 - Actinogen Limited (ASX:ACW) CEO Dr Bill Ketelbey discusses how the company is pursuing treatment of Alzheimer’s disease.

Actinogen: ASX Investor Series

27 Apr 2015 - Actinogen Limited (ASX:ACW) CEO Dr Bill Ketelbey presents at the ASX Investor Series in Sydney.

Actinogen raises $10M for Alzheimer drug

24 Apr 2015 - Actinogen Limited (ASX:ACW) raises $10 million through an institutional placement that will go towards a Phase II trial of its promising Alzheimer drug Xanamem.

Midday: ASX higher despite US losses

24 Mar 2015 - ASX higher despite US losses. Biotechnology company Actinogen Limited (ASX:ACW) announces positive results from a clinical trial of the Xanamem alzheimers dementia dr…